Nabriva Therapeutics PLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Nabriva Therapeutics PLC
CIK #0001703287, 0001641640
EDGAR Form CIK 2011 - 2026
10-K [0001641640]
10-Q [0001641640]
3 [0001641640]
4 [0001641640]
6-K [0001641640]
8-K [0001641640]
D [0001641640]
SC 13D [0001641640]
SC 13G [0001641640]
3 [0001703287]
4 [0001703287]
8-K [0001703287]
Form 13D/13G Filer Form 13D/13G Subject Filed
Lincoln Park Capital Fund LLC Nabriva Therapeutics PLC [2021-11-19]
FMR LLC Nabriva Therapeutics PLC [2020-02-07]
Longitude Capital Partners II LLC Nabriva Therapeutics PLC [2018-08-07]
Frazier Healthcare VII LP Nabriva Therapeutics PLC [2018-08-03]
Wellington Management Group LLP Nabriva Therapeutics PLC [2018-04-10]
Wellington Management Group LLP Nabriva Therapeutics AG [2017-02-09]
Novo A/S Nabriva Therapeutics AG [2016-07-29]
venBio Global Strategic Fund II LP Nabriva Therapeutics AG [2016-04-29]
Wellington Management Group LLP Nabriva Therapeutics AG [2016-03-23]
Phase4 Partners Ltd Nabriva Therapeutics AG [2016-02-12]
View All
Form 3/4/5 Subject 2011 - 2026
Hogan H Michael III
Nabriva Therapeutics AG
Maggio David
Gelone Steven P
Schroeder Theodore R
Naftzger J Christopher
Dolan Daniel
Guico-Pabia Christine J
Webster Stephen W
Burgess Daniel D
Broom Colin MD
Corrigan Mark
Dalton Lisa
Rowland Charles A Jr
Bourdow Carrie L
Crotty Robert
Sender Gary
Schranz Jennifer
Lavino Francesco Maria
Talbot George Harrison
Vivo Capital VIII LLC
HBM BioVentures Cayman Ltd
Nabriva Therapeutics Legacy PLC
Khuong Chau Quang
Seltzer Elyse G
Bolte Axel
Isaly Samuel D
OrbiMed Advisors LLC
OrbiMed Capital GP V LLC
Wolf John Peter III
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Nabriva Therapeutics AG NBRV
Ordinary Shares
2023-01-29 Tax withheld 140 $1.50 210
Nabriva Therapeutics AG NBRV
Ordinary Shares
2023-01-29 Tax withheld 431 $1.50 646
Nabriva Therapeutics AG NBRV
Ordinary Shares
2023-01-06 Tax withheld 11 $1.30 14
Nabriva Therapeutics AG NBRV
Ordinary Shares
2023-01-06 Tax withheld 5 $1.30 6
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-12-31 Tax withheld 3 $1.89 6
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-12-31 Tax withheld 5 $1.89 9
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-12-06 Tax withheld 9 $2.02 18
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-12-06 Tax withheld 4 $2.02 8
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-11-30 Tax withheld 3 $2.25 7
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-11-30 Tax withheld 5 $2.25 11
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-11-06 Tax withheld 4 $2.24 9
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-11-06 Tax withheld 10 $2.24 22
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-10-31 Tax withheld 5 $2.54 13
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-10-31 Tax withheld 3 $2.54 8
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-10-06 Tax withheld 9 $2.72 24
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-10-06 Tax withheld 4 $2.72 11
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-09-30 Tax withheld 5 $2.08 10
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-09-30 Tax withheld 3 $2.08 6
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-09-06 Tax withheld 225 $0.16 36
Nabriva Therapeutics AG NBRV
Ordinary Shares
2022-09-06 Tax withheld 89 $0.16 14
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com